healthcor management  coworking space in new york foursquarelog insign upnearbyget inspiredtop pickstrendingfoodcoffeenightlifefunshoppingplanning a trip to new yorkfoursquare can help you find the best places to go tofind great things to dohealthcor managementcoworking spacetheater district new yorksavesharetipsphotos healthcor managementno tips and reviewslog in to leave a tip herepostno tips yetwrite a short note about what you liked what to order or other helpful advice for visitors photorelated searcheshealthcor management new york  healthcor management new york photos  healthcor management new york location  healthcor management new york address  healthcor management new york  healthcor management new york  healthcor management theater district new yorkaboutblogbusinessescitiesdevelopershelpjobscookies updatedprivacy updatedtermsenglishenglish français deutsch bahasa indonesia italiano  한국어 português русский español ภาษาไทย türkçe citiesatlantaaustinbostonchicagodallasdenverhoustonlas vegaslos angelesnew yorkphiladelphiaportlandsan diegosan franciscoseattlewashington dccountriesbelgiumbrazilcanadachilefinlandfrancegermanygreat britainhungaryindonesiajapanmexiconetherlandsphilippinesrussiasingaporespainthailandturkeymore great places in new yorkabcdefghijklmnopqrstuvwxyzfoursquare    lovingly made in nyc  sfhealthcor management w th st th and th avenew york ny united statesget directions see moretop places in the areathe  best places for sunsets in new york citythe  best places with scenic views in new york cityunited states » new york » new york » theater districtprofessional  other places » office » coworking spaceis this your business claim it nowmake sure your information is up to date plus use our free tools to find new customersyou must enable javascript to use foursquarecomwe use the latest and greatest technology available to provide the best possible web experienceplease enable javascript in your browser settings to continuedownload foursquare for your smart phone and start exploring the world around you arthur b cohen and joseph healey  healthcor management lp   stock picks and performance  insider monkey companies  see all hedge funds  see all insiders  see all institutional investors  see all click here to see all results for sorry no results has been found matching your query adblocker detected dear valued visitor we have noticed that you are using an ad blocker software although advertisements on the web pages may degrade your experience our business certainly depends on them and we can only keep providing you highquality research based articles as long as we can display ads on our pages to view this article you can disable your ad blocker and refresh this page or simply login we only allow registered users to use ad blockers you can sign up for free by clicking here or you can login if you are already a member home  hedge funds  healthcor management lp  profile hedge fund  healthcor management lp get email alerts profile holdings latest d  g filings news interviews and investor letters get email alerts profile holdings latest d  g filing news arthur b cohen and joseph healey bio returns net worth healthcor management is a  billion healthcare hedge fund founded by arthur cohen and joseph healey cohen graduated from the university of virginia in  with a ba degree in commerce and received his mba in banking and finance from hofstra university in  he worked for julian robertson between  and  he was responsible for healthcare investments as a managing director at tiger management he partnered with joseph p healey in september  the duo worked at steven cohen’s sac until  healthcor management is a  billion healthcare hedge fund founded by arthur cohen and joseph healey cohen graduated from the university of virginia in  with a ba degree in commerce and received his mba in banking and finance from hofstra university in  he worked for julian robertson between  and  he was responsible for healthcare investments as a managing director at tiger management he partnered with joseph p healey in september  the duo worked at steven cohen’s sac until healey is a brilliant stock picker see joseph healey’s stock recommendations at the  ira sohn conference healthcor returned  in  vs  for an average hedge fund cohen and healey invest significant amounts in the healthcare industry by diversifying their portfolio in different stocks nearly two thirds of his investments are in the healthcare sector show more fund profile filing period                            fund name healthcor management lp manager arthur b cohen and joseph healey portfolio value  change this qtr  top holdings login to see all holdings  sign up filing period                            last updated on may    pm based on sec f filings last update may    pm no security ticker shares value x activity  port  bioverativ inc     aetna inc aet      celgene corp celg      laboratory corp of america holdings lh      edwards lifesciences corp ew    login to see all holdings  sign up its free latest d  g filings login to see all filings  sign up company symbol filed by filing date filing careview communications inc crvwob healthcor management lp  d filing bioverativ inc bivv healthcor management lp  g filing careview communications inc crvwob healthcor management lp  d filing corindus vascular robotics inc cvrs healthcor management lp  d filing login to see all filings  sign up its free news interviews and investor letters see all d filing healthcor management lp and careview communications inc crvw  read more july th   hedge funds  comments g filing healthcor management lp and bioverativ inc bivv  read more april th   hedge funds  comments top picks of healthcarefocused asset manager run by former sac capital traders healthcor management lp was cofounded by joseph healey and arthur cohen two former sac capital advisors traders in  in fact the founders of the new yorkbased longshort equity hedge fund were read more june st   hedge fund analysis hedge funds news  comments healthcor management lp increases stake in clovis oncology inc clvs arthur b cohen and joseph healeys healthcor management has filed a g with the securities and exchange commission disclosing its position in clovis oncology inc nasdaqclvs the filing showed that read more march th   hedge funds news  comments icahn cuts stake in gannett co inc gci sandell gives up on ethan allen interiors inc eth plus two other moves shareholder activism has been surging over the past several years with the shareholder activism arena managing approximately  billion in assets under management activist hedge funds are currently read more january th   hedge funds news  comments a look at steve cohen’s latest portfolio addition  two other hedge fund bullish moves at insider monkey we follow around  hedge funds and other institutional investors and ahead of the new year several funds from our database have reported some interesting moves in this article we read more december st   hedge funds news  comments healthcor management likes these  healthcare stocks amid sector turbulence arthur b cohen and joseph healeys healthcor management has nearly  billion worth of regulatory assets under its management the healthcarefocused fund which has  of its equity portfolio invested read more december th   hedge fund analysis hedge funds news  comments healthcor management’s core health picks for q healthcor management lp is a new yorkbased healthcarefocused hedge fund founded by arthur cohen and joseph healey in  prior to forming the fund both cohen and healey worked for steve cohens read more august th   hedge fund analysis hedge funds news  comments conatus pharmaceuticals inc cnat healthcor takes large stake see conatus’ needham healthcare conference presentation inside healthcor management lp managed by arthur b cohen and joseph p healey has revealed a large new passive position in conatus pharmaceuticals inc nasdaqcnat of just over  million shares giving read more april th   hedge funds news  comments mallinckrodt plc mnk pfizer inc pfe healthcor management’s top  health stocks arthur b cohen and joseph healey’s healthcor management lp recently filed its latest f with the sec disclosing its equity positions at the end of  there has been a great deal of turnover among read more march nd   hedge funds news  comments allscripts healthcare solutions inc mdrx healthcor management lp cuts stake to  healthcor management lp managed by arthur b cohen and joseph healey has cut its activist stake in allscripts healthcare solutions inc nasdaqmdrx to  from  a newly amended filing with the read more september th   hedge funds news  comments healthcor management initiates exposure to oxygen biotherapeutics inc oxbt arthur cohen and joseph healeys healthcor management has added oxygen biotherapeutics inc nasdaqoxbt to its equity portfolio the fund revealed holding  million shares of the company the stake read more march st   hedge funds news  comments healthcor management further invests in careview communications inc crvw arthur cohen and joseph healeys hedge fund healthcor management has further increased its exposure to careview communications inc otcbbcrvw healthcor currently owns around  million shares read more january rd   hedge funds news  comments healthcor management increases holding in careview communications inc crvw arthur cohen and joseph healeys healthcor management has upped its exposure to careview communications inc otcbbcrvw healthcor currently owns around  million shares of the company up from read more january th   hedge funds news  comments healthcor management reduces position in allscripts healthcare solutions inc mdrx arthur cohen and joseph healeys healthcor management revealed in a newly amended filing with the sec decreasing its holding in allscripts healthcare solutions inc nasdaqmdrx currently owning  read more december th   hedge funds news  comments click here to see all news hedge fund resource center how to beat the market by  percentage points why track hedge funds download a free edition why you should dump your hedge funds  things you didnt know about hedge funds billionaire hedge funds warren buffett berkshire hathaway  david einhorn greenlight capital  george soros soros fund management  t boone pickens bp capital  jim simons renaissance technologies  leon cooperman omega advisors  carl icahn icahn capital lp  steve cohen point asset management  john paulson paulson  co  david tepper appaloosa management lp  paul tudor jones tudor investment corp  stanley druckenmiller duquesne capital  julian robertson tiger management  ray dalio bridgewater associates  ken fisher fisher asset management  bill ackman pershing square  edward lampert esl investments  dan loeb third point  ken griffin citadel investment group  israel englander millennium management  michael price mfp investors  home hedge funds markets blog authors about us contact us privacy policy terms of use site map all text and design is copyright  koala guide llc all rights reserved healthcor partners management lp  welcome home about us team portfolio news contact healthcor partners management lp late stage venture and growth equityhealthcare investor improving carelowering costs engaged partnerstrusted advisors building businessesof strategic value explore home about us team portfolio news contact get in touch carnegie hall tower west th streetnew york ny   sand hill roadmenlo park ca  t  f    healthcor partners management lp all rights reserved bizapediacom  human validation companiespeopleproductsservicestrademarksaddressesphone book our system has detected a high number of page requests from your ip address please prove to us that you are a human to continue using our website please send me to the search subscription offer page after i successfully answer the word challenge bizapediapro searchperform unlimited searches via ouradvanced search form withbizapedia pro searchfind out more bizapediapro databuild custom data listsfor one or many stateswith bizapedia pro datafind out more  copyright   · bizapediacom · all rights reservedblogpro searchpro apicontact usterms of useprivacy policysitemapdesktop version healthcor partners management lp private company information  bloomberg july    pm et capital markets company overview of healthcor partners management lp snapshot people company overview healthcor partners management lp is a private equity firm specializing in leveraged buyouts middle market acquisitions buildups restructurings recapitalizations and special situations the firm prefers to invest in laterstage developmental and growing midsized companies across it considers investing in healthcare and life sciences industry with a focus on diagnostics medtech and devices therapeutics and healthcare services the firm typically makes equity and equityrelated investments between  million and  million in each portfolio company it seeks to make minority andor control investments in later stage developmental companies and significant minority andor control healthcor partners management lp is a private equity firm specializing in leveraged buyouts middle market acquisitions buildups restructurings recapitalizations and special situations the firm prefers to invest in laterstage developmental and growing midsized companies across it considers investing in healthcare and life sciences industry with a focus on diagnostics medtech and devices therapeutics and healthcare services the firm typically makes equity and equityrelated investments between  million and  million in each portfolio company it seeks to make minority andor control investments in later stage developmental companies and significant minority andor control investments in rapidly growing private or publicly traded midsized companies healthcor partners management lp is based in new york new york it operates as a subsidiary of healthcor management lp detailed description  west th streetcarnegie hall towernew york ny united states wwwhealthcorpartnerscom key executives for healthcor partners management lp mr jeffrey c lightcap senior managing director age  mr arthur b cohen cfa senior managing director mr joseph patrick healey cfa senior managing director dr michael y mashaal md managing director age  ms elizabeth miller compensation as of fiscal year  similar private companies by industry company name region visory llc united states  road partners llc united states t partners llc united states jumpcom inc united states  ontario inc united states recent private companies transactions typedate target private placement february   corindus vascular robotics inc request profile update   the information and data displayed in this profile are created and managed by sp global market intelligence a division of sp global bloombergcom does not create or control the content for inquiries please contact sp global market intelligence directly by clicking here stock quotes market data is delayed at least  minutes company lookup most searched private companies company name geographic region lawyers committee for civil rights under law united states nyc inc united states the advertising council inc united states bertelsmann ag europe rush university united states sponsored financial commentaries sponsored links browse companies a b c d e f g h i j k l m n o p q r s t u v w x y z              request profile update only a company representative may request an update for the company profile documentation will be required to contact healthcor partners management lp please visit wwwhealthcorpartnerscom company data is provided by sp global market intelligence please use this form to report any data issues information missing  please enter your information in the following fields company name your name your email address your phone number type of data overview executives key developments similar companies transactions update needed all data changes require verification from public sources please include the correct value or values and a source where we can verify cancel submit your requested update has been submitted our data partners will research the update request and update the information on this page if necessary research and followup could take several weeks if you have questions you can contact them at bwwebmasterbusinessweekcom close healthcor partners management lp  contact home about us team portfolio news contact contact locations new york carnegie hall tower  west th street new york ny  view on maps tel  fax  menlo park  sand hill road menlo park ca  view on maps leave us a message message send explore home about us team portfolio news contact get in touch carnegie hall tower west th streetnew york ny   sand hill roadmenlo park ca  t  f    healthcor partners management lp all rights reserved healthcor partners management lp  team home about us team portfolio news contact team   jeffrey c lightcap senior managing director michael y mashaal md managing director ed ross associate jeffrey c lightcap senior managing director founded healthcor partners in  prior to joining healthcor partners mr lightcap was a senior managing director at jll partners a leading middlemarket private equity fund from  to mid prior to jll partners mr lightcap was a managing director at merrill lynch  co inc merrill lynch in charge of leverage buyout coverage for merrill lynchs mergers and acquisitions group prior to joining merrill lynch mr lightcap was a senior vice president in the mergers and acquisitions group at kidder peabody  co and briefly at salomon brothersmr lightcap received a be in mechanical engineering from the state university of new york in  and an mba from the university of chicago in mr lightcap serves on the board of directors of a number of companies including iasis healthcare corporation paradigm spine practice partners in healthcare corindus careview communications and heartflow  previously mr lightcap served on the board of directors of accessclosure acquired by cardinal health sadra medical acquired by boston scientific in addition to service on other private company boardsmichael y mashaal md managing director also a founding partner of healthcor partners joined healthcor group in september  prior to joining the private equity team in  dr mashaal was a senior research analyst focused on biotechnology for the healthcor group from  to  previously from  to  dr mashaal served as a research analyst focused on healthcare and biotechnology for several large institutional investment firmsdr mashaal graduated from emory university in  with a ba in biology after receiving an md at state university of new york at stony brook school of medicine in  dr mashaal trained in general surgery at the university hospital at stony brook from  to dr mashaal currently serves on the board of directors of reshape medical and also serves as a board observer of heartflow and paradigm spine previously dr mashaal served on the board of directors of apatech acquired by baxter velcera acquired by perrigo and corindus vascular robotics served as a board observer of natera in addition to service on other private company boardsed ross associate joined healthcor partners in september  prior to healthcor ed was an analyst with baltimorebased moag  company a boutique investment bank focused on the sports industrymr ross graduated from the university of north carolina at chapel hill in  with a bs in business administration elizabeth miller operations associate lauren paroulek executive assistant elizabeth miller operations associate joined healthcor partners in  prior to joining the private equity team elizabeth was an associate at healthcor management lp from  to ms miller graduated from union college in  with a ba in psychologylauren paroulek executive assistant joined healthcor partners in   prior to joining healthcor partners ms paroulek served operational roles at several corporationsms paroulek received a ba in communication disorders from the state university of new york at new paltz in  and a masters degree in library and information studies from the city university of new york at queens college in  explore home about us team portfolio news contact get in touch carnegie hall tower west th streetnew york ny   sand hill roadmenlo park ca  t  f    healthcor partners management lp all rights reserved healthcor partners management lp  portfolio home about us team portfolio news contact portfolio   all current realized disruptive innovator in vascular closure devices with the industry leading mynx product family location mountain view california investment stage growth equity sector biomaterials investment status realized acquired by cardinal health founded  company status na partnered  develops and commercializes actifuse® a new class of bioactive synthetic bone graft materials that provide both bone support as well as bone growth stimulation location london england investment stage growth equity sector biomaterials investment status realized acquired by baxter international inc founded  company status na partnered  specializes in developing and marketing intelligent bedside video monitoring systems that enhance patient care and safety location lewisville texas investment stage growth equity sector hcit investment status current founded  company status public partnered  visit website developing a proprietary platform endovascular technology designed to protect patients from the risk of stroke during left heart procedures and vascular interventions location santa rosa ca investment stage late stage sector medical devices investment status current founded  company status private partnered  leader in precision vascular robotics with its fdacleared corpath system® location waltham massachusets investment stage growth equity sector medical devices investment status current founded  company status public partnered  visit website develops and markets more accurate diagnostic tests for coronary artery disease which combines the power of computing with a standard ct image to noninvasively provide anatomical and physiological information such as blood flow within specific vessels location redwood city california investment stage growth equity sector diagnostics investment status current founded  company status private partnered  visit website dedicated to acquiring and marketing legacy and commercial stage branded pharmaceutical drugs for the north american markets location toronto canada investment stage buildup sector specialty pharmaceuticals investment status current founded  company status private partnered  visit website developing technology that enables the enrichment and isolation of fetal cells from maternal blood with high specificity and allows for early diagnostic assessment of genetically inherited disorders location great river new york investment stage late stage sector diagnostics investment status current founded  company status private partnered  visit website develops and markets gene based diagnostic tests that leverage its proprietary bioinformatics technology natera intitially focused its efforts on prenatal testing and is quickly expanding into other areas of medicine location san carlos california investment stage growth equity sector diagnostics investment status current founded  company status public partnered  visit website global provider of surgeon centric indication specific and data driven implants for the treatment of spine disease paradigm’s lead product is the coflex® nonfusion interlaminar stabilization device which has more than  years of clinical history and patients treated in more than  countries worldwide location new york new york investment stage growth equity sector medical devices investment status current founded  company status private partnered  visit website develops and manages ambulatory surgery centers with leading physicians primarily in the southeast and midwest location birmingham alabama investment stage growth equity sector services investment status current founded  company status private partnered  visit website developing an innovative high value diagnostic tests focused on assessing a woman’s risk for preterm delivery early in pregnancy location great river new york investment stage late stage sector diagnostics investment status current founded  company status private partnered  develops and commercializes minimally invasive devices and other solutions for patients seeking weight loss without risk of surgery or side effects of drugs location san clemente ca investment stage growth equity sector medical devices investment status current founded  company status private partnered  focused on developing the lotus valve a minimally invasive alternative to traditional surgical aortic valve replacement in patients with aortic valve disease location los gatos california investment stage late stage sector medical devices investment status realized acquired by boston scientific corporation founded  company status na partnered  develops and markets best in class companion pet healthproducts that contain the same active ingredients as leading branded veterinary products but sold directly to the consumer at a significantly lower cost location yardley pennsylvania investment stage growth equity sector therapeutics investment status realized acquired by perrigo company founded  company status na partnered  specializes in developing and marketing intelligent bedside video monitoring systems that enhance patient care and safety location lewisville texas investment stage growth equity sector hcit investment status current founded  company status public partnered  visit website developing a proprietary platform endovascular technology designed to protect patients from the risk of stroke during left heart procedures and vascular interventions location santa rosa ca investment stage late stage sector medical devices investment status current founded  company status private partnered  leader in precision vascular robotics with its fdacleared corpath system® location waltham massachusets investment stage growth equity sector medical devices investment status current founded  company status public partnered  visit website develops and markets more accurate diagnostic tests for coronary artery disease which combines the power of computing with a standard ct image to noninvasively provide anatomical and physiological information such as blood flow within specific vessels location redwood city california investment stage growth equity sector diagnostics investment status current founded  company status private partnered  visit website dedicated to acquiring and marketing legacy and commercial stage branded pharmaceutical drugs for the north american markets location toronto canada investment stage buildup sector specialty pharmaceuticals investment status current founded  company status private partnered  visit website developing technology that enables the enrichment and isolation of fetal cells from maternal blood with high specificity and allows for early diagnostic assessment of genetically inherited disorders location great river new york investment stage late stage sector diagnostics investment status current founded  company status private partnered  visit website develops and markets gene based diagnostic tests that leverage its proprietary bioinformatics technology natera intitially focused its efforts on prenatal testing and is quickly expanding into other areas of medicine location san carlos california investment stage growth equity sector diagnostics investment status current founded  company status public partnered  visit website global provider of surgeon centric indication specific and data driven implants for the treatment of spine disease paradigm’s lead product is the coflex® nonfusion interlaminar stabilization device which has more than  years of clinical history and patients treated in more than  countries worldwide location new york new york investment stage growth equity sector medical devices investment status current founded  company status private partnered  visit website develops and manages ambulatory surgery centers with leading physicians primarily in the southeast and midwest location birmingham alabama investment stage growth equity sector services investment status current founded  company status private partnered  visit website developing an innovative high value diagnostic tests focused on assessing a woman’s risk for preterm delivery early in pregnancy location great river new york investment stage late stage sector diagnostics investment status current founded  company status private partnered  develops and commercializes minimally invasive devices and other solutions for patients seeking weight loss without risk of surgery or side effects of drugs location san clemente ca investment stage growth equity sector medical devices investment status current founded  company status private partnered  disruptive innovator in vascular closure devices with the industry leading mynx product family location mountain view california investment stage growth equity sector biomaterials investment status realized acquired by cardinal health founded  company status na partnered  develops and commercializes actifuse® a new class of bioactive synthetic bone graft materials that provide both bone support as well as bone growth stimulation location london england investment stage growth equity sector biomaterials investment status realized acquired by baxter international inc founded  company status na partnered  focused on developing the lotus valve a minimally invasive alternative to traditional surgical aortic valve replacement in patients with aortic valve disease location los gatos california investment stage late stage sector medical devices investment status realized acquired by boston scientific corporation founded  company status na partnered  develops and markets best in class companion pet healthproducts that contain the same active ingredients as leading branded veterinary products but sold directly to the consumer at a significantly lower cost location yardley pennsylvania investment stage growth equity sector therapeutics investment status realized acquired by perrigo company founded  company status na partnered  explore home about us team portfolio news contact get in touch carnegie hall tower west th streetnew york ny   sand hill roadmenlo park ca  t  f    healthcor partners management lp all rights reserved healthcor management lp aboutinvestment approachstrategyexecutive committeegovernancegiving backcontact contact healthcor management lp fundamental healthcare investment managerestablished about ushealthcor is an experienced value based investor that is dedicated to identifying global healthcare and life science equity securities that are mispricedhealthcor management lps healthcor two cofounders joe healey and art cohen have an extensive career of equity investing in the sector through numerous market cycles and have coinvested together for over  years as a team  from its base in new york city healthcor launched its longshort equity hedge fund strategy on september   since then healthcor has leveraged its security selection expertise across a platform of healthcare focused products  healthcor became registered with the securities exchange commission as an investment adviser on march   under the us investment advisers act of  as amendedinvestment approachhealthcor uses a bottomup fundamental research driven approach to security selectionhealthcor’s investment professionals  leverage their specialized knowledge of key medical scientific regulatory and intellectual property data with a bottomup fundamental research driven approach to security selection  idea generation is catalyst driven and every position is judged on its own ability to generate profits consistent with its risk reward profile the firm is characterized by intensive financial analysis and places a premium on strong balance sheets cash flow top line organic growth and earnings revisions as well as management teams that seek to grow shareholder value healthcor takes into account industry themes such as utilization consolidation and regulatory activity when investing and concentrates in high conviction names which demonstrate margin of safety attributesthe firm invests on a balanced basis across the sector where it organizes itself around the major subsectors of pharmaceuticals medtech biotech services strategyhealthcor’s investment strategies have different risk reward objectives consistent with their mandates the longshort equity strategy for example seeks to achieve superior riskadjusted returns through investments in equity and equityrelated instruments and has demonstrated a proven ability to preserve capital in down markets the strategy employs a modest amount of leverage and a large short portfolio predominantly consisting of stock specific ideas each intended to generate profits   all healthcor strategies benefit from the same rigorous bottomup fundamental research process focused on generating the best ideas for security selection while employing a disciplined and structured approach to portfolio management in addition healthcor acts as a subadviser to several multimanager mutual funds and a ucits fund separately healthcors affiliate healthcor partners management lp manages a private equity strategy which is a separately registered entityidea generation is catalyst driven and every position is judged on its own ability to generate profits consistent with its risk reward profileexecutive committee  senior management arthur cohen cfacofounder  portfolio manager joseph healey cfacofounder  portfolio manager avi horevsenior partner  portfolio manager arthur cohen cfa cofounder  portfolio managercofounder and portfolio manager of healthcor prior to healthcor art was a portfolio manager at sac capital advisors llc “sac” from january  through march  together with joe healey prior to sac from  to  art was responsible for healthcare investments as a managing director at tiger management prior to tiger from  to  art was a vp and investment officer at jw seligman a vp at bank of new york from  to  and an assistant portfolio manageranalyst of the msb fund from  to  art graduated from the university of virginia in  with a ba in commerce and received his mba in banking and finance from hofstra university in joseph healey cfa cofounder  portfolio managercofounder and portfolio manager of healthcor prior to healthcor joe was a portfolio manager at sac capital advisors llc “sac” from january  through march  together with art cohen prior to sac from  to  joe was a healthcare portfolio manager at kingdon capital management and from  until  was an analyst and portfolio manager at dreyfus corporation joe also served as a first lieutenant in the us army medical service corp at the walter reed army medical center from  to  joe graduated from boston university in  with a ba in biomedical engineering and received his ms in technology management from the university of maryland in avi horev senior partner  portfolio managersenior partner and portfolio manager of healthcor avi joined healthcor at the time of its launch in  from  to  avi worked with art and joe’s team as a medical device research analyst at sac capital advisors llc “sac” prior to working at sac avi was employed as a healthcare equity research analyst at jp morgan from  to  avi graduated with a bs in finance from lehigh university in  lori pricedirector of research christine clarkechief financial officer nasine damdirector of technology anabelle perez graygeneral counsel  chief compliance officer lori price director of researchlori joined healthcor in  prior to healthcor lori was a managing director and global head of health care servicessenior equity analyst at jp morgan chase  co inc prior to jp morgan she was managing director and senior health care services analyst at cibc world marketsoppenheimer  co inc senior analyst at seidler amdec securities inc and senior vice president at houlihan lokey howard  zukin inc lori graduated from ucla graduate school of management in  with a ba in economics and received her mba in finance and marketing in christine clarke chief financial officerchristine joined healthcor in october  as controller  in july  christine was promoted to chief financial officer prior to joining healthcor christine was the controller at narragansett management lp for two years where she was responsible for accounting and operational duties of several onshore and offshore vehicles  christine also managed relationships with prime brokers fund administrators and auditors  from  until  christine was an assurance senior associate at pricewaterhousecoopers llp where she conducted audits of investment management clients christine received a bs in accounting from fordham university in  and is also a certified public accountantnasine dam director of technologynasine joined healthcor in  prior to joining healthcor nasine served as an assistant vicepresident at banc of america securities in their prime brokerage division there he oversaw the day to day technical operations of new york boston texas and london hedge fund clients  prior to banc of america securities he was a trade floor support specialist at bnp paribas before venturing to manhattan nasine spent his earlier career working out of boston at state street global advisors as a pc engineer from  until   he also supported putnam investments’ trading floor as a desktop support specialist from  through   nasine started his career at fleet boston financial group as a technical analyst supporting the company’s trading floor from  until  nasine received a bs in business administration from northeastern university in anabelle perez gray general counsel  chief compliance officeranabelle joined healthcor in  prior to joining healthcor anabelle served as legal counsel at man investments a multiplatform global alternatives manager prior to man investments anabelle served as director deputy general counsel and chief compliance officer at financial risk management’s new york adviser later purchased by man investments where she ran the us compliance program and conducted diligence on hedge fund managers anabelle began her legal career in  at hughes hubbard  reed where she was a corporate associate and then went on to katten muchin rosenman llp where she focused on hedge fund formation  prior to that anabelle was a journalist anabelle graduated from the university of delaware in  with a ba in english and also received her ms in publishing from new york university in  she received a jd in  from boston college law school arthur cohen cfacofounder  portfolio manager arthur cohen cfa cofounder  portfolio managercofounder and portfolio manager of healthcor prior to healthcor art was a portfolio manager at sac capital advisors llc “sac” from january  through march  together with joe healey prior to sac from  to  art was responsible for healthcare investments as a managing director at tiger management prior to tiger from  to  art was a vp and investment officer at jw seligman a vp at bank of new york from  to  and an assistant portfolio manageranalyst of the msb fund from  to  art graduated from the university of virginia in  with a ba in commerce and received his mba in banking and finance from hofstra university in  joseph healey cfacofounder  portfolio manager joseph healey cfa cofounder  portfolio managercofounder and portfolio manager of healthcor prior to healthcor joe was a portfolio manager at sac capital advisors llc “sac” from january  through march  together with art cohen prior to sac from  to  joe was a healthcare portfolio manager at kingdon capital management and from  until  was an analyst and portfolio manager at dreyfus corporation joe also served as a first lieutenant in the us army medical service corp at the walter reed army medical center from  to  joe graduated from boston university in  with a ba in biomedical engineering and received his ms in technology management from the university of maryland in  avi horevsenior partner  portfolio manager avi horev senior partner  portfolio managersenior partner and portfolio manager of healthcor avi joined healthcor at the time of its launch in  from  to  avi worked with art and joe’s team as a medical device research analyst at sac capital advisors llc “sac” prior to working at sac avi was employed as a healthcare equity research analyst at jp morgan from  to  avi graduated with a bs in finance from lehigh university in  lori pricedirector of research lori price director of researchlori joined healthcor in  prior to healthcor lori was a managing director and global head of health care servicessenior equity analyst at jp morgan chase  co inc prior to jp morgan she was managing director and senior health care services analyst at cibc world marketsoppenheimer  co inc senior analyst at seidler amdec securities inc and senior vice president at houlihan lokey howard  zukin inc lori graduated from ucla graduate school of management in  with a ba in economics and received her mba in finance and marketing in  christine clarkechief financial officer christine clarke chief financial officerchristine joined healthcor in october  as controller  in july  christine was promoted to chief financial officer prior to joining healthcor christine was the controller at narragansett management lp for two years where she was responsible for accounting and operational duties of several onshore and offshore vehicles  christine also managed relationships with prime brokers fund administrators and auditors  from  until  christine was an assurance senior associate at pricewaterhousecoopers llp where she conducted audits of investment management clients christine received a bs in accounting from fordham university in  and is also a certified public accountant nasine damdirector of technology nasine dam director of technologynasine joined healthcor in  prior to joining healthcor nasine served as an assistant vicepresident at banc of america securities in their prime brokerage division there he oversaw the day to day technical operations of new york boston texas and london hedge fund clients  prior to banc of america securities he was a trade floor support specialist at bnp paribas before venturing to manhattan nasine spent his earlier career working out of boston at state street global advisors as a pc engineer from  until   he also supported putnam investments’ trading floor as a desktop support specialist from  through   nasine started his career at fleet boston financial group as a technical analyst supporting the company’s trading floor from  until  nasine received a bs in business administration from northeastern university in  anabelle perez graygeneral counsel  chief compliance officer anabelle perez gray general counsel  chief compliance officeranabelle joined healthcor in  prior to joining healthcor anabelle served as legal counsel at man investments a multiplatform global alternatives manager prior to man investments anabelle served as director deputy general counsel and chief compliance officer at financial risk management’s new york adviser later purchased by man investments where she ran the us compliance program and conducted diligence on hedge fund managers anabelle began her legal career in  at hughes hubbard  reed where she was a corporate associate and then went on to katten muchin rosenman llp where she focused on hedge fund formation  prior to that anabelle was a journalist anabelle graduated from the university of delaware in  with a ba in english and also received her ms in publishing from new york university in  she received a jd in  from boston college law school governancehealthcor has  an advisory committee as part of its ongoing effort to align interests and pursue best practices that benefit its stake holdersthe advisory committee is an additional layer of oversight and corporate governance with respect to the management of the hedge fund strategy and is comprised of four industry experts who are independent of healthcor the advisory committee’s industry experts have extensive experience in the areas of hedge fund law accounting manager research due diligence corporate governance healthcor as well as healthcor offshore gp llc the general partner of the hedge fund strategy works with the advisory committee to provide it with information necessary to enable the advisory committee to make informed decisionsin addition healthcor  recognizes the risk and benefits that responsible investing adds to returns and thus integrates environmental social and governance esg considerations into its investment process the firms cofounders have coinvested in healthcare and life sciences through numerous market cycles together for over  yearsgiving backhealthcor’s values go beyond strong productive teamwork in the workplace and extend to organizations where the firm feels it can have an impacthealthcor through an affiliated entity healthcor foundation trust strongly believes in supporting the communities where we work and live and the community interests of our employees  through the healthcor foundation trust matching gift program employees can double the impact of their charitable giving by leveraging the firm’s support  to date the firm has donated to over a  charities additionally these values are exemplified in the work by the healthcor foundation trust which helped to fund the young scholars’ academy for discovery  exploration’s student library which opened in early  the healthcor foundation trust also awards donation opportunities to eligible charities as prizes to the winners of employeewide athletic competitions charities are selected by the competition winnerscontact usfor inquiries please contact lori price director of research by completing the form below healthcor management lp carnegie hall tower west th streetnew york ny  view on maps tel  fax  explore aboutinvestment approachstrategyexecutive committee governancegiving backcontact   healthcor management lp all rights reserved healthcor partners management lp  about us home about us team portfolio news contact about us healthcor partners management lp healthcor partners is a registered investment advisor with the us securities and exchange commission the “sec” together with its affiliate healthcor partners has approximately  million of capital commitments dedicated to healthcare private equity investments healthcor partners invests primarily in growth equity and later stage developmental companies across all sectors of the healthcare and life sciences industry healthcor partners is an affiliate of healthcor management lp healthcor management a registered investment advisor with the sec providing investment management services to several privately offered pooled investment funds primarily in the healthcare and life sciences sector healthcor management centers its investment strategy on indepth and fundamental research together healthcor partners and healthcor management comprise the healthcor group the healthcor group through its principals and investment professionals has developed deep institutional knowledge of and extensive contacts across the healthcare and life sciences industry   in addition to being able to leverage the healthcor groups research and public equity expertise healthcor partners is differentiated from other middlemarket healthcare or life sciences private equity firms by the breadth of its investment focus which includes medtech and devices therapeutics healthcare services healthcare information technology and diagnostics this broad focus not only provides fund diversification but also creates a deeper context for identifying and understanding the continual interactions among the different sectors of the healthcare and life sciences industry healthcor partners believes its comprehensive view of this interplay provides important and meaningful insights in evaluating making and monitoring its investments portfolio companies view all therapeutics diagnostics medtech services develops and markets more accurate diagnostic tests for coronary artery disease which combines the power of computing with a standard ct image to noninvasively provide anatomical and physiological information such as blood flow within specific vessels location redwood city california investment stage growth equity sector diagnostics investment status current founded  company status private partnered  visit website dedicated to acquiring and marketing legacy and commercial stage branded pharmaceutical drugs for the north american markets location toronto canada investment stage buildup sector specialty pharmaceuticals investment status current founded  company status private partnered  visit website specializes in developing and marketing intelligent bedside video monitoring systems that enhance patient care and safety location lewisville texas investment stage growth equity sector hcit investment status current founded  company status public partnered  visit website developing a proprietary platform endovascular technology designed to protect patients from the risk of stroke during left heart procedures and vascular interventions location santa rosa ca investment stage late stage sector medical devices investment status current founded  company status private partnered  develops and commercializes minimally invasive devices and other solutions for patients seeking weight loss without risk of surgery or side effects of drugs location san clemente ca investment stage growth equity sector medical devices investment status current founded  company status private partnered  develops and markets best in class companion pet healthproducts that contain the same active ingredients as leading branded veterinary products but sold directly to the consumer at a significantly lower cost location yardley pennsylvania investment stage growth equity sector therapeutics investment status realized acquired by perrigo company founded  company status na partnered  focused on developing the lotus valve a minimally invasive alternative to traditional surgical aortic valve replacement in patients with aortic valve disease location los gatos california investment stage late stage sector medical devices investment status realized acquired by boston scientific corporation founded  company status na partnered  leader in precision vascular robotics with its fdacleared corpath system® location waltham massachusets investment stage growth equity sector medical devices investment status current founded  company status public partnered  visit website develops and commercializes actifuse® a new class of bioactive synthetic bone graft materials that provide both bone support as well as bone growth stimulation location london england investment stage growth equity sector biomaterials investment status realized acquired by baxter international inc founded  company status na partnered  global provider of surgeon centric indication specific and data driven implants for the treatment of spine disease paradigm’s lead product is the coflex® nonfusion interlaminar stabilization device which has more than  years of clinical history and patients treated in more than  countries worldwide location new york new york investment stage growth equity sector medical devices investment status current founded  company status private partnered  visit website disruptive innovator in vascular closure devices with the industry leading mynx product family location mountain view california investment stage growth equity sector biomaterials investment status realized acquired by cardinal health founded  company status na partnered  developing an innovative high value diagnostic tests focused on assessing a woman’s risk for preterm delivery early in pregnancy location great river new york investment stage late stage sector diagnostics investment status current founded  company status private partnered  developing technology that enables the enrichment and isolation of fetal cells from maternal blood with high specificity and allows for early diagnostic assessment of genetically inherited disorders location great river new york investment stage late stage sector diagnostics investment status current founded  company status private partnered  visit website develops and markets gene based diagnostic tests that leverage its proprietary bioinformatics technology natera intitially focused its efforts on prenatal testing and is quickly expanding into other areas of medicine location san carlos california investment stage growth equity sector diagnostics investment status current founded  company status public partnered  visit website develops and manages ambulatory surgery centers with leading physicians primarily in the southeast and midwest location birmingham alabama investment stage growth equity sector services investment status current founded  company status private partnered  visit website explore home about us team portfolio news contact get in touch carnegie hall tower west th streetnew york ny   sand hill roadmenlo park ca  t  f    healthcor partners management lp all rights reserved healthcor management lp aboutinvestment approachstrategyexecutive committeegovernancegiving backcontact contact healthcor management lp fundamental healthcare investment managerestablished about ushealthcor is an experienced value based investor that is dedicated to identifying global healthcare and life science equity securities that are mispricedhealthcor management lps healthcor two cofounders joe healey and art cohen have an extensive career of equity investing in the sector through numerous market cycles and have coinvested together for over  years as a team  from its base in new york city healthcor launched its longshort equity hedge fund strategy on september   since then healthcor has leveraged its security selection expertise across a platform of healthcare focused products  healthcor became registered with the securities exchange commission as an investment adviser on march   under the us investment advisers act of  as amendedinvestment approachhealthcor uses a bottomup fundamental research driven approach to security selectionhealthcor’s investment professionals  leverage their specialized knowledge of key medical scientific regulatory and intellectual property data with a bottomup fundamental research driven approach to security selection  idea generation is catalyst driven and every position is judged on its own ability to generate profits consistent with its risk reward profile the firm is characterized by intensive financial analysis and places a premium on strong balance sheets cash flow top line organic growth and earnings revisions as well as management teams that seek to grow shareholder value healthcor takes into account industry themes such as utilization consolidation and regulatory activity when investing and concentrates in high conviction names which demonstrate margin of safety attributesthe firm invests on a balanced basis across the sector where it organizes itself around the major subsectors of pharmaceuticals medtech biotech services strategyhealthcor’s investment strategies have different risk reward objectives consistent with their mandates the longshort equity strategy for example seeks to achieve superior riskadjusted returns through investments in equity and equityrelated instruments and has demonstrated a proven ability to preserve capital in down markets the strategy employs a modest amount of leverage and a large short portfolio predominantly consisting of stock specific ideas each intended to generate profits   all healthcor strategies benefit from the same rigorous bottomup fundamental research process focused on generating the best ideas for security selection while employing a disciplined and structured approach to portfolio management in addition healthcor acts as a subadviser to several multimanager mutual funds and a ucits fund separately healthcors affiliate healthcor partners management lp manages a private equity strategy which is a separately registered entityidea generation is catalyst driven and every position is judged on its own ability to generate profits consistent with its risk reward profileexecutive committee  senior management arthur cohen cfacofounder  portfolio manager joseph healey cfacofounder  portfolio manager avi horevsenior partner  portfolio manager arthur cohen cfa cofounder  portfolio managercofounder and portfolio manager of healthcor prior to healthcor art was a portfolio manager at sac capital advisors llc “sac” from january  through march  together with joe healey prior to sac from  to  art was responsible for healthcare investments as a managing director at tiger management prior to tiger from  to  art was a vp and investment officer at jw seligman a vp at bank of new york from  to  and an assistant portfolio manageranalyst of the msb fund from  to  art graduated from the university of virginia in  with a ba in commerce and received his mba in banking and finance from hofstra university in joseph healey cfa cofounder  portfolio managercofounder and portfolio manager of healthcor prior to healthcor joe was a portfolio manager at sac capital advisors llc “sac” from january  through march  together with art cohen prior to sac from  to  joe was a healthcare portfolio manager at kingdon capital management and from  until  was an analyst and portfolio manager at dreyfus corporation joe also served as a first lieutenant in the us army medical service corp at the walter reed army medical center from  to  joe graduated from boston university in  with a ba in biomedical engineering and received his ms in technology management from the university of maryland in avi horev senior partner  portfolio managersenior partner and portfolio manager of healthcor avi joined healthcor at the time of its launch in  from  to  avi worked with art and joe’s team as a medical device research analyst at sac capital advisors llc “sac” prior to working at sac avi was employed as a healthcare equity research analyst at jp morgan from  to  avi graduated with a bs in finance from lehigh university in  lori pricedirector of research christine clarkechief financial officer nasine damdirector of technology anabelle perez graygeneral counsel  chief compliance officer lori price director of researchlori joined healthcor in  prior to healthcor lori was a managing director and global head of health care servicessenior equity analyst at jp morgan chase  co inc prior to jp morgan she was managing director and senior health care services analyst at cibc world marketsoppenheimer  co inc senior analyst at seidler amdec securities inc and senior vice president at houlihan lokey howard  zukin inc lori graduated from ucla graduate school of management in  with a ba in economics and received her mba in finance and marketing in christine clarke chief financial officerchristine joined healthcor in october  as controller  in july  christine was promoted to chief financial officer prior to joining healthcor christine was the controller at narragansett management lp for two years where she was responsible for accounting and operational duties of several onshore and offshore vehicles  christine also managed relationships with prime brokers fund administrators and auditors  from  until  christine was an assurance senior associate at pricewaterhousecoopers llp where she conducted audits of investment management clients christine received a bs in accounting from fordham university in  and is also a certified public accountantnasine dam director of technologynasine joined healthcor in  prior to joining healthcor nasine served as an assistant vicepresident at banc of america securities in their prime brokerage division there he oversaw the day to day technical operations of new york boston texas and london hedge fund clients  prior to banc of america securities he was a trade floor support specialist at bnp paribas before venturing to manhattan nasine spent his earlier career working out of boston at state street global advisors as a pc engineer from  until   he also supported putnam investments’ trading floor as a desktop support specialist from  through   nasine started his career at fleet boston financial group as a technical analyst supporting the company’s trading floor from  until  nasine received a bs in business administration from northeastern university in anabelle perez gray general counsel  chief compliance officeranabelle joined healthcor in  prior to joining healthcor anabelle served as legal counsel at man investments a multiplatform global alternatives manager prior to man investments anabelle served as director deputy general counsel and chief compliance officer at financial risk management’s new york adviser later purchased by man investments where she ran the us compliance program and conducted diligence on hedge fund managers anabelle began her legal career in  at hughes hubbard  reed where she was a corporate associate and then went on to katten muchin rosenman llp where she focused on hedge fund formation  prior to that anabelle was a journalist anabelle graduated from the university of delaware in  with a ba in english and also received her ms in publishing from new york university in  she received a jd in  from boston college law school arthur cohen cfacofounder  portfolio manager arthur cohen cfa cofounder  portfolio managercofounder and portfolio manager of healthcor prior to healthcor art was a portfolio manager at sac capital advisors llc “sac” from january  through march  together with joe healey prior to sac from  to  art was responsible for healthcare investments as a managing director at tiger management prior to tiger from  to  art was a vp and investment officer at jw seligman a vp at bank of new york from  to  and an assistant portfolio manageranalyst of the msb fund from  to  art graduated from the university of virginia in  with a ba in commerce and received his mba in banking and finance from hofstra university in  joseph healey cfacofounder  portfolio manager joseph healey cfa cofounder  portfolio managercofounder and portfolio manager of healthcor prior to healthcor joe was a portfolio manager at sac capital advisors llc “sac” from january  through march  together with art cohen prior to sac from  to  joe was a healthcare portfolio manager at kingdon capital management and from  until  was an analyst and portfolio manager at dreyfus corporation joe also served as a first lieutenant in the us army medical service corp at the walter reed army medical center from  to  joe graduated from boston university in  with a ba in biomedical engineering and received his ms in technology management from the university of maryland in  avi horevsenior partner  portfolio manager avi horev senior partner  portfolio managersenior partner and portfolio manager of healthcor avi joined healthcor at the time of its launch in  from  to  avi worked with art and joe’s team as a medical device research analyst at sac capital advisors llc “sac” prior to working at sac avi was employed as a healthcare equity research analyst at jp morgan from  to  avi graduated with a bs in finance from lehigh university in  lori pricedirector of research lori price director of researchlori joined healthcor in  prior to healthcor lori was a managing director and global head of health care servicessenior equity analyst at jp morgan chase  co inc prior to jp morgan she was managing director and senior health care services analyst at cibc world marketsoppenheimer  co inc senior analyst at seidler amdec securities inc and senior vice president at houlihan lokey howard  zukin inc lori graduated from ucla graduate school of management in  with a ba in economics and received her mba in finance and marketing in  christine clarkechief financial officer christine clarke chief financial officerchristine joined healthcor in october  as controller  in july  christine was promoted to chief financial officer prior to joining healthcor christine was the controller at narragansett management lp for two years where she was responsible for accounting and operational duties of several onshore and offshore vehicles  christine also managed relationships with prime brokers fund administrators and auditors  from  until  christine was an assurance senior associate at pricewaterhousecoopers llp where she conducted audits of investment management clients christine received a bs in accounting from fordham university in  and is also a certified public accountant nasine damdirector of technology nasine dam director of technologynasine joined healthcor in  prior to joining healthcor nasine served as an assistant vicepresident at banc of america securities in their prime brokerage division there he oversaw the day to day technical operations of new york boston texas and london hedge fund clients  prior to banc of america securities he was a trade floor support specialist at bnp paribas before venturing to manhattan nasine spent his earlier career working out of boston at state street global advisors as a pc engineer from  until   he also supported putnam investments’ trading floor as a desktop support specialist from  through   nasine started his career at fleet boston financial group as a technical analyst supporting the company’s trading floor from  until  nasine received a bs in business administration from northeastern university in  anabelle perez graygeneral counsel  chief compliance officer anabelle perez gray general counsel  chief compliance officeranabelle joined healthcor in  prior to joining healthcor anabelle served as legal counsel at man investments a multiplatform global alternatives manager prior to man investments anabelle served as director deputy general counsel and chief compliance officer at financial risk management’s new york adviser later purchased by man investments where she ran the us compliance program and conducted diligence on hedge fund managers anabelle began her legal career in  at hughes hubbard  reed where she was a corporate associate and then went on to katten muchin rosenman llp where she focused on hedge fund formation  prior to that anabelle was a journalist anabelle graduated from the university of delaware in  with a ba in english and also received her ms in publishing from new york university in  she received a jd in  from boston college law school governancehealthcor has  an advisory committee as part of its ongoing effort to align interests and pursue best practices that benefit its stake holdersthe advisory committee is an additional layer of oversight and corporate governance with respect to the management of the hedge fund strategy and is comprised of four industry experts who are independent of healthcor the advisory committee’s industry experts have extensive experience in the areas of hedge fund law accounting manager research due diligence corporate governance healthcor as well as healthcor offshore gp llc the general partner of the hedge fund strategy works with the advisory committee to provide it with information necessary to enable the advisory committee to make informed decisionsin addition healthcor  recognizes the risk and benefits that responsible investing adds to returns and thus integrates environmental social and governance esg considerations into its investment process the firms cofounders have coinvested in healthcare and life sciences through numerous market cycles together for over  yearsgiving backhealthcor’s values go beyond strong productive teamwork in the workplace and extend to organizations where the firm feels it can have an impacthealthcor through an affiliated entity healthcor foundation trust strongly believes in supporting the communities where we work and live and the community interests of our employees  through the healthcor foundation trust matching gift program employees can double the impact of their charitable giving by leveraging the firm’s support  to date the firm has donated to over a  charities additionally these values are exemplified in the work by the healthcor foundation trust which helped to fund the young scholars’ academy for discovery  exploration’s student library which opened in early  the healthcor foundation trust also awards donation opportunities to eligible charities as prizes to the winners of employeewide athletic competitions charities are selected by the competition winnerscontact usfor inquiries please contact lori price director of research by completing the form below healthcor management lp carnegie hall tower west th streetnew york ny  view on maps tel  fax  explore aboutinvestment approachstrategyexecutive committee governancegiving backcontact   healthcor management lp all rights reserved healthcor partners management lp  about us home about us team portfolio news contact about us healthcor partners management lp healthcor partners is a registered investment advisor with the us securities and exchange commission the “sec” together with its affiliate healthcor partners has approximately  million of capital commitments dedicated to healthcare private equity investments healthcor partners invests primarily in growth equity and later stage developmental companies across all sectors of the healthcare and life sciences industry healthcor partners is an affiliate of healthcor management lp healthcor management a registered investment advisor with the sec providing investment management services to several privately offered pooled investment funds primarily in the healthcare and life sciences sector healthcor management centers its investment strategy on indepth and fundamental research together healthcor partners and healthcor management comprise the healthcor group the healthcor group through its principals and investment professionals has developed deep institutional knowledge of and extensive contacts across the healthcare and life sciences industry   in addition to being able to leverage the healthcor groups research and public equity expertise healthcor partners is differentiated from other middlemarket healthcare or life sciences private equity firms by the breadth of its investment focus which includes medtech and devices therapeutics healthcare services healthcare information technology and diagnostics this broad focus not only provides fund diversification but also creates a deeper context for identifying and understanding the continual interactions among the different sectors of the healthcare and life sciences industry healthcor partners believes its comprehensive view of this interplay provides important and meaningful insights in evaluating making and monitoring its investments portfolio companies view all therapeutics diagnostics medtech services develops and markets more accurate diagnostic tests for coronary artery disease which combines the power of computing with a standard ct image to noninvasively provide anatomical and physiological information such as blood flow within specific vessels location redwood city california investment stage growth equity sector diagnostics investment status current founded  company status private partnered  visit website dedicated to acquiring and marketing legacy and commercial stage branded pharmaceutical drugs for the north american markets location toronto canada investment stage buildup sector specialty pharmaceuticals investment status current founded  company status private partnered  visit website specializes in developing and marketing intelligent bedside video monitoring systems that enhance patient care and safety location lewisville texas investment stage growth equity sector hcit investment status current founded  company status public partnered  visit website developing a proprietary platform endovascular technology designed to protect patients from the risk of stroke during left heart procedures and vascular interventions location santa rosa ca investment stage late stage sector medical devices investment status current founded  company status private partnered  develops and commercializes minimally invasive devices and other solutions for patients seeking weight loss without risk of surgery or side effects of drugs location san clemente ca investment stage growth equity sector medical devices investment status current founded  company status private partnered  develops and markets best in class companion pet healthproducts that contain the same active ingredients as leading branded veterinary products but sold directly to the consumer at a significantly lower cost location yardley pennsylvania investment stage growth equity sector therapeutics investment status realized acquired by perrigo company founded  company status na partnered  focused on developing the lotus valve a minimally invasive alternative to traditional surgical aortic valve replacement in patients with aortic valve disease location los gatos california investment stage late stage sector medical devices investment status realized acquired by boston scientific corporation founded  company status na partnered  leader in precision vascular robotics with its fdacleared corpath system® location waltham massachusets investment stage growth equity sector medical devices investment status current founded  company status public partnered  visit website develops and commercializes actifuse® a new class of bioactive synthetic bone graft materials that provide both bone support as well as bone growth stimulation location london england investment stage growth equity sector biomaterials investment status realized acquired by baxter international inc founded  company status na partnered  global provider of surgeon centric indication specific and data driven implants for the treatment of spine disease paradigm’s lead product is the coflex® nonfusion interlaminar stabilization device which has more than  years of clinical history and patients treated in more than  countries worldwide location new york new york investment stage growth equity sector medical devices investment status current founded  company status private partnered  visit website disruptive innovator in vascular closure devices with the industry leading mynx product family location mountain view california investment stage growth equity sector biomaterials investment status realized acquired by cardinal health founded  company status na partnered  developing an innovative high value diagnostic tests focused on assessing a woman’s risk for preterm delivery early in pregnancy location great river new york investment stage late stage sector diagnostics investment status current founded  company status private partnered  developing technology that enables the enrichment and isolation of fetal cells from maternal blood with high specificity and allows for early diagnostic assessment of genetically inherited disorders location great river new york investment stage late stage sector diagnostics investment status current founded  company status private partnered  visit website develops and markets gene based diagnostic tests that leverage its proprietary bioinformatics technology natera intitially focused its efforts on prenatal testing and is quickly expanding into other areas of medicine location san carlos california investment stage growth equity sector diagnostics investment status current founded  company status public partnered  visit website develops and manages ambulatory surgery centers with leading physicians primarily in the southeast and midwest location birmingham alabama investment stage growth equity sector services investment status current founded  company status private partnered  visit website explore home about us team portfolio news contact get in touch carnegie hall tower west th streetnew york ny   sand hill roadmenlo park ca  t  f    healthcor partners management lp all rights reserved healthcor partners management lp  news home about us team portfolio news contact news   all news portfolio company news healthcor news page                                           page                                           page  explore home about us team portfolio news contact get in touch carnegie hall tower west th streetnew york ny   sand hill roadmenlo park ca  t  f    healthcor partners management lp all rights reserved microsoft personalized ad preferences to opt out of personalized ads in this browser your browser history must allow firstparty and thirdparty cookies and you must have your browsing experience set to not delete browsing history on exit instructions for enabling cookies and configuring your browsing history may be available in your browsers settings privacy or help documentation sign in hold on… we’re sorry but this didn’t work you can’t turn off personalized ads right now because your browser is currently blocking thirdparty cookies we can help you fix this issue let’s get started depending on what browser you use open options or settings make sure that thirdparty cookies are not blocked anymore to find out how search your browser’s help revisit httpchoicemicrosoftcomoptout and then on the “personalized ads in this browser” tile click off ext about our ads to create a more customized online experience some of the ads you may receive on microsoft websites and apps are tailored to your previous activities searches and site visits youre in control and heres where you can make the advertising choice thats right for you ext where can i learn more about advertising on microsoft websites and apps microsoft partners with oath appnexus and other third party service providers to help present customized content and display advertisements on msn outlookcom and other websites and apps microsoft also delivers search ads to bing and our search syndication partners learn more about microsoft’s privacy practices here you can learn more about interestbased ads from oath and appnexus in their privacy statements oath and appnexus what choices do i have about interestbased advertising on this page you can opt out of receiving interest based advertising from microsoft you can also opt out of receiving interestbased advertising from all selfregulatory members including microsoft oath appnexus and other third party ad networks at the following sites in the us digital advertising alliance daa in europe european interactive digital advertising alliance edaa in canada ad choices digital advertising alliance of canada daac you can control interestbased advertising in windows apps by turning off the advertising id in windows settings more choices do you want personalized ads from other companies questions if you have a privacy question or a question for the chief privacy officer of microsoft please contact us by using our web form we will respond to questions within  days ext personalized ads in this browser off optout is currently unavailable please try again later control the personalized ads setting for this web browser learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off ext personalized ads wherever i use my microsoft account off sign in to change optout is currently unavailable please try again later control the personalized ads setting that applies when you are signed in on any computer or device with your microsoft account including windows windows phone xbox and other devices learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off if you choose “generic” ads and use a browser your choice applies to everyone when using that browser as long as you do not clear your cookies ext personalized ads in windows in your windows settings you can turn off personalized ads that appear in apps on this device you’ll still see ads but they won’t be personalized anymore if you have windows  access the charms by touching or moving your pointer to the right edge of the screen click or tap settings and then click or tap change pc settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have windows  click or tap the start button click or tap settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have a windows mobile device go to settings tap on privacy tap on advertising id and then turn off let apps use my advertising id for experiences across apps if you want to turn off personalized ads from microsoft wherever you use your microsoft account including apps on windows windows phone xbox and other devices you can do so by selecting the microsoft account option above ext legal privacy  cookies   microsoft healthcor management lp company profile outlook business segments competitors goods and services swot and financial analysis sales and support     uk     us infomarketpublisherscom business  finance retail retail consumer goods food  beverage industry chemicals it  technology life sciences services about faq my cart market reports pressreleases events about us terms  conditions customer faq market research reports company reports healthcor management lp company profile outlook business segments competitors goods and services swot and financial analysis date november   pages  price us  license  electronic eg pdf  us  hard copy  us  cdromsite licence  us  enterprisewide  us  publisher og analysis report type strategic report delivery email delivery pdf hard copy mail delivery id hcfdien leaflet download pdf leaflet abstracts contents list of figures healthcor management lp company profile is a complete analysis of the companys operations strategies outlook and historic performance the research work analyzes key strategies in current market conditions swot profile future plans and projects being planned by the company current operations potential segments along with its key advantages which provide an edge over its competitors are detailed healthcor management lps business description products services and projects are detailed in the report further key brands operating locations subsidiaries and affiliates are analyzed in detail healthcor management lp company profile competitors are listed along with ceos annual outlook statement key employees organization structure and contact information is analyzed further ma deals expansion and asset purchase plans of the company are also detailed detailed swot and financial analysis of healthcor management lp are included in the research work key events in the history of the company and all latest updates of the company are provided  table of contents  list of tables  list of figures  healthcor management lp snapshot  healthcor management lp overview  business strategies and outlook  stock information  healthcor management lp locations subsidiaries and affiliates  operating areas  subsidiaries  affiliate jv companies  healthcor management lp swot profile  strengths  weaknesses  opportunities  threats  healthcor management lp outlook statement healthcor management lp history healthcor management lp business operation structure  business overview  operations by segments  healthcor management lp products and services  key products  key services  healthcor management lpkey competitors healthcor management lp management and key employees healthcor management lp financial analysis and statements  income statements  cash flow statements  balance sheet  healthcor management lp contact information healthcor management lp recent developments appendix  about oganalysis  sources and research methodology financial analysis will be provided for the latest year as reported by the companytable  healthcor management lp key snapshot table  healthcor management lp geographic locations table  key events and history table  healthcor management lp income statements table  healthcor management lp balance sheet table  cash flow statements list of figuresfigure  swot analysis figure  financial statementscompanies mentionedhealthcor management lp skip to top more publications advantage risk management co ltd company profile outlook business segments competitors goods and services swot and financial analysis us  nov  ·  pages amanet management  systems ltd company profile outlook business segments competitors goods and services swot and financial analysis us  nov  ·  pages energy management international inc company profile outlook business segments competitors goods and services swot and financial analysis us  nov  ·  pages enervest management partners ltd company profile outlook business segments competitors goods and services swot and financial analysis us  nov  ·  pages greensmith energy management systems llc company profile outlook business segments competitors goods and services swot and financial analysis us  nov  ·  pages ask your question healthcor management lp company profile outlook business segments competitors goods and services swot and financial analysis company name contact person phonefax email request invoice your enquiry please click on a check box below to confirm you are not a robot market reports all categories sales and support         infomarketpublisherscom   marketpublisherscom about us our clients our publishers customer faq market reports new publications reports by regions pressreleases terms  conditions privacy policy return policy affiliate program join as publisher follow us swot analysis reports  company profiles sales and support     uk     us infomarketpublisherscom business  finance finance services banking cards credit  loans financial company reports investment mortgage payment other financial services insurance general insurance health insurance insurance company reports life insurance property insurance reinsurance auto insurance business services accounting  tax services advertising brokerage business support business services company reports consulting diversified services company reports franchise wealth management company reports business survey real estate retail retail cash  carry convenience stores department stores duty free hypermarkets  supermarkets online retail retail company reports service station retail specialist store wholesale consumer goods consumer products company reports cosmetics  hygiene products furnishing jewelry  accessories household products pet products sporting goods  equipment stationery textile  leather tobacco toys  games food  beverage alcoholic drinks soft drinks food food  beverage company reports industry agriculture agribusiness agricultural products animal husbandry fisheries fertilizers gardening  forestry construction building materials building products company reports commercial construction engineering  construction services company report industrial construction infrastructure residential construction energy alternative energy batteries  accumulators electric power energy company reports nuclear power smart grid thermal power metallurgy alkali metals ferrous metallurgy metal alloys metal products metals  mining company reports nonferrous metallurgy precious metals rareearth metals uranous metals actinoid mineral raw materials building raw materials  fillers conglomerates company reports fossil fuel nonmetallic minerals metalloids ores precious  semiprecious stones machinery  equipment defence  security packaging industry publishing industry pulp  paper vehicle other industries chemicals organic chemicals alcohols alkenes olefins ethers organic acids  derivatives aldehydes  ketones amines halogenated polymers alkanes benzene  derivatives isocyanates inorganic chemicals alkali inorganic salts nonmetallic oxides inorganic acids metal oxides chemical company reports chemical reports by cas number composite materials oils  lubricants it  technology consumer electronics audio  video equipment gps navigation mobile phones  smartphones pc  notebooks photography hardware computer hardware computers  electronic equipment company reports data storage networking hardware software application software operating system programming software software development software  technology services company reports video games telecommunications broadband communication services company reports internet mobile networks telecom equipment wireless technology life sciences medical devices anesthesia  respiratory cardiovascular devices dental diabetes care diagnostic equipment drug delivery endoscopy ear nose  throat ent healthcare equipmentsupplies company reports implants neurology orthopedic ophthalmic surgical equipment wound closure other medical devices biotechnology biomarkers biomaterials biosimilars stem cell diagnostics  diseases in vitro diagnostics incontinence cancer cardiovascular diabetes hepatitis healthcare healthcare services company reports ear care eye care hospital medicated skin care therapy wound care pharmaceuticals clinical trial drug stores drugs pharmaceuticals company reports vaccines medical products veterinary services freight  trucking air freight freight  trucking company reports rail freight road freight water freight media  entertainment casino and gaming cinema  theater magazine  newspaper media company reports music social media television  radio food service fast food restaurants restaurants  leisure company reports pub  bar consumer services education hotels legal services logistics post  courier recruitment rent sports  fitness center travel  leisure other services about faq my cart market reports pressreleases events about us terms  conditions customer faq market research reports company reports swot analysis reports  company profiles a legal entity created on a voluntary basis and engaged in a certain business company can operate in different market and counties a company size is measured on the basis of its market value sales assets or profits as a rule companies are represented by the following types be private public government unlimited foreign producer to name a few typical departments found in almost any company comprise but are not limited to production customer services marketing human resources finance to name a few exxon mobil jpmorgan chase shell apple royal dutch shell and toyota motor are amidst the globe’s largest and most influential companies with most of them active the world over this catalogue’s research reports cover companies involved in various business activities be it production sales marketing etc the reports contain information on companies’ activities historical development key executives departments product offerings swot analyses data on market share marketing strategies the most recent activities within the industry acquisitions strategic partnerships and alliances are included in the research reports swot analysis reports all regions  global africa east asia and pacific europe middle east north america south america global africa algeria angola botswana cameroon cape verde ivory coast egypt ethiopia gabon ghana kenya liberia mauritania mauritius morocco mozambique namibia nigeria reunion rwanda senegal seychelles sierra leone south africa tanzania togo tunisia uganda zambia zimbabwe libya cote divoire sudan east asia and pacific australia bangladesh brunei darussalam cambodia china fiji hong kong india indonesia japan north korea south korea macau malaysia marshall islands mongolia nepal new zealand pakistan papua new guinea philippines singapore sri lanka taiwan thailand vietnam europe germany russia belarus ukraine andorra austria belgium bosnia and herzegovina bulgaria croatia czech republic denmark estonia faroe islands finland france gibraltar greece hungary iceland ireland italy latvia liechtenstein lithuania luxembourg macedonia malta monaco netherlands norway poland portugal romania san marino slovakia slovenia spain sweden switzerland united kingdom montenegro serbia middle east israel armenia azerbaijan bahrain cyprus georgia jordan kazakhstan kuwait lebanon oman qatar saudi arabia turkey united arab emirates uzbekistan yemen afghanistan iran iraq syria north america united states canada anguilla bahamas barbados belize bermuda cayman islands costa rica dominican republic el salvador greenland guatemala honduras jamaica mexico netherlands antilles panama puerto rico trinidad and tobago cuba south america argentina bolivia brazil chile colombia ecuador falkland islands paraguay peru suriname venezuela company reports all publishers  regions afs research alpha street research amid aruvians rsearch bac company reports bac industry comparative analysis bac market reports bac swot company reports barnes reports beijing zeefer consulting bras research business strategies group china research and intelligence cni research currentpartnering daedal research datagroup booksellers datamining euromonitor international fours services private limited future markets global industry analysts global markets direct globaldata guangzhou ccm information science  technology idata research india business reports information trends intellectual property exchange is advisors kalorama information lnganalysis market and business development market insights co ltd market intelligence  consulting institute mic marketline mp advisors netscribes noealt corporate services og analysis omi advisories ovum plimsoll publishing renub research researchinchina sadia saeed sdi smart research insights sri krishna bharathi knowledge services skbks stellar analytics stratecore research llp techsci research timetric value market research venture planning group visiongain world market intelligence found  publications wuxi nextcode genomics  medical equipment  deals and alliances profile us   deals database and primary and secondary research scope financial deals  analysis of the companys financial deals including mergers and acquisitions equitydebt offerings private equity venture financing and partnerships deals by year  jul   pages vium inc  medical equipment  deals and alliances profile us   deals database and primary and secondary research scope financial deals  analysis of the companys financial deals including mergers and acquisitions equitydebt offerings private equity venture financing and partnerships deals by year  jul   pages the university of melbourne  medical equipment  deals and alliances profile us   deals database and primary and secondary research scope financial deals  analysis of the companys financial deals including mergers and acquisitions equitydebt offerings private equity venture financing and partnerships deals by year  jul   pages temple university  medical equipment  deals and alliances profile us   deals database and primary and secondary research scope financial deals  analysis of the companys financial deals including mergers and acquisitions equitydebt offerings private equity venture financing and partnerships deals by year  jul   pages sygnis ag lio  medical equipment  deals and alliances profile us   deals database and primary and secondary research scope financial deals  analysis of the companys financial deals including mergers and acquisitions equitydebt offerings private equity venture financing and partnerships deals by year  jul   pages sun pharmaceutical industries ltd sunpharma  medical equipment  deals and alliances profile us   sun pharmaceutical industries ltd sunpharma  medical equipment  deals and alliances profile provides you comprehensive data and trend analysis of the companys mergers and acquisitions mas partnerships and financings  jul   pages stada arzneimittel ag saz  medical equipment  deals and alliances profile us   deals database and primary and secondary research scope financial deals  analysis of the companys financial deals including mergers and acquisitions equitydebt offerings private equity venture financing and partnerships deals by year  jul   pages spinal elements inc  medical equipment  deals and alliances profile us   deals database and primary and secondary research scope financial deals  analysis of the companys financial deals including mergers and acquisitions equitydebt offerings private equity venture financing and partnerships deals by year  jul   pages serum institute of india ltd  medical equipment  deals and alliances profile us   india serum institute of india ltd  medical equipment  deals and alliances profile provides you comprehensive data and trend analysis of the companys mergers and acquisitions mas partnerships and financings  jul   pages sensodetect ab  medical equipment  deals and alliances profile us   deals database and primary and secondary research scope financial deals  analysis of the companys financial deals including mergers and acquisitions equitydebt offerings private equity venture financing and partnerships deals by year  jul   pages second military medical university  medical equipment  deals and alliances profile us   second military medical university  medical equipment  deals and alliances profile provides you comprehensive data and trend analysis of the companys mergers and acquisitions mas partnerships and financings the report provides detailed  jul   pages scibase ab scib  medical equipment  deals and alliances profile us   deals database and primary and secondary research scope financial deals  analysis of the companys financial deals including mergers and acquisitions equitydebt offerings private equity venture financing and partnerships deals by year  jul   pages savara inc svra  medical equipment  deals and alliances profile us   deals database and primary and secondary research scope financial deals  analysis of the companys financial deals including mergers and acquisitions equitydebt offerings private equity venture financing and partnerships deals by year  jul   pages sartorius ag srt  medical equipment  deals and alliances profile us   deals database and primary and secondary research scope financial deals  analysis of the companys financial deals including mergers and acquisitions equitydebt offerings private equity venture financing and partnerships deals by year  jul   pages sanquin blood supply foundation  medical equipment  deals and alliances profile us   sanquin blood supply foundation  medical equipment  deals and alliances profile provides you comprehensive data and trend analysis of the companys mergers and acquisitions mas partnerships and financings  jul   pages recipharm ab reci b  medical equipment  deals and alliances profile us   deals database and primary and secondary research scope financial deals  analysis of the companys financial deals including mergers and acquisitions equitydebt offerings private equity venture financing and partnerships deals by year  jul   pages queens university belfast  medical equipment  deals and alliances profile us   deals database and primary and secondary research scope financial deals  analysis of the companys financial deals including mergers and acquisitions equitydebt offerings private equity venture financing and partnerships deals by year  jul   pages phaserx inc pzrx  medical equipment  deals and alliances profile us   deals database and primary and secondary research scope financial deals  analysis of the companys financial deals including mergers and acquisitions equitydebt offerings private equity venture financing and partnerships deals by year  jul   pages parexel international corp prxl  medical equipment  deals and alliances profile us   deals database and primary and secondary research scope financial deals  analysis of the companys financial deals including mergers and acquisitions equitydebt offerings private equity venture financing and partnerships deals by year  jul   pages organogenesis inc  medical equipment  deals and alliances profile us   deals database and primary and secondary research scope financial deals  analysis of the companys financial deals including mergers and acquisitions equitydebt offerings private equity venture financing and partnerships deals by year  jul   pages octreopharm sciences gmbh  medical equipment  deals and alliances profile us   deals database and primary and secondary research scope financial deals  analysis of the companys financial deals including mergers and acquisitions equitydebt offerings private equity venture financing and partnerships deals by year  jul   pages novocure ltd nvcr  medical equipment  deals and alliances profile us   deals database and primary and secondary research scope financial deals  analysis of the companys financial deals including mergers and acquisitions equitydebt offerings private equity venture financing and partnerships deals by year  jul   pages nexeon medsystems inc  medical equipment  deals and alliances profile us   deals database and primary and secondary research scope financial deals  analysis of the companys financial deals including mergers and acquisitions equitydebt offerings private equity venture financing and partnerships deals by year  jul   pages neuroderm ltd ndrm  medical equipment  deals and alliances profile us   deals database and primary and secondary research scope financial deals  analysis of the companys financial deals including mergers and acquisitions equitydebt offerings private equity venture financing and partnerships deals by year  jul   pages mednet solutions inc  medical equipment  deals and alliances profile us   deals database and primary and secondary research scope financial deals  analysis of the companys financial deals including mergers and acquisitions equitydebt offerings private equity venture financing and partnerships deals by year  jul   pages medipines corp  medical equipment  deals and alliances profile us   deals database and primary and secondary research scope financial deals  analysis of the companys financial deals including mergers and acquisitions equitydebt offerings private equity venture financing and partnerships deals by year  jul   pages maastricht university  medical equipment  deals and alliances profile us   deals database and primary and secondary research scope financial deals  analysis of the companys financial deals including mergers and acquisitions equitydebt offerings private equity venture financing and partnerships deals by year  jul   pages livanova plc livn  medical equipment  deals and alliances profile us   deals database and primary and secondary research scope financial deals  analysis of the companys financial deals including mergers and acquisitions equitydebt offerings private equity venture financing and partnerships deals by year  jul   pages leo pharma as  medical equipment  deals and alliances profile us   deals database and primary and secondary research scope financial deals  analysis of the companys financial deals including mergers and acquisitions equitydebt offerings private equity venture financing and partnerships deals by year  jul   pages atum  pharmaceuticals  healthcare  deals and alliances profile us   deals database and primary and secondary research scope financial deals  analysis of the companys financial deals including mergers and acquisitions equitydebt offerings private equity venture financing and partnerships deals by year  jul   pages ascendance biotechnology inc  pharmaceuticals  healthcare  deals and alliances profile us   deals database and primary and secondary research scope financial deals  analysis of the companys financial deals including mergers and acquisitions equitydebt offerings private equity venture financing and partnerships deals by year  jul   pages ascend therapeutics us llc  pharmaceuticals  healthcare  deals and alliances profile us   deals database and primary and secondary research scope financial deals  analysis of the companys financial deals including mergers and acquisitions equitydebt offerings private equity venture financing and partnerships deals by year  jul   pages arrien pharmaceuticals llc  pharmaceuticals  healthcare  deals and alliances profile us   deals database and primary and secondary research scope financial deals  analysis of the companys financial deals including mergers and acquisitions equitydebt offerings private equity venture financing and partnerships deals by year  jul   pages amyris inc amrs  pharmaceuticals  healthcare  deals and alliances profile us   deals database and primary and secondary research scope financial deals  analysis of the companys financial deals including mergers and acquisitions equitydebt offerings private equity venture financing and partnerships deals by year  jul   pages alzheimers drug discovery foundation  pharmaceuticals  healthcare  deals and alliances profile us   new york the us alzheimers drug discovery foundation  pharmaceuticals  healthcare  deals and alliances profile provides you comprehensive data and trend analysis of the companys mergers and acquisitions mas partnerships and financings  jul   pages alfred e tiefenbacher gmbh  co kg  pharmaceuticals  healthcare  deals and alliances profile us   deals database and primary and secondary research scope financial deals  analysis of the companys financial deals including mergers and acquisitions equitydebt offerings private equity venture financing and partnerships deals by year  jul   pages agilent technologies inc a  pharmaceuticals  healthcare  deals and alliances profile us   deals database and primary and secondary research scope financial deals  analysis of the companys financial deals including mergers and acquisitions equitydebt offerings private equity venture financing and partnerships deals by year  jul   pages adial pharmaceuticals llc  pharmaceuticals  healthcare  deals and alliances profile us   deals database and primary and secondary research scope financial deals  analysis of the companys financial deals including mergers and acquisitions equitydebt offerings private equity venture financing and partnerships deals by year  jul   pages aarhus university  pharmaceuticals  healthcare  deals and alliances profile us   deals database and primary and secondary research scope financial deals  analysis of the companys financial deals including mergers and acquisitions equitydebt offerings private equity venture financing and partnerships deals by year  jul   pages ppharma sas  pharmaceuticals  healthcare  deals and alliances profile us   pharma etrack deals database and primary and secondary research scope financial deals  analysis of the companys financial deals including mergers and acquisitions equitydebt offerings private equity venture financing and partnerships deals by year  jul   pages p biopharmaceuticals sl  pharmaceuticals  healthcare  deals and alliances profile us   deals database and primary and secondary research scope financial deals  analysis of the companys financial deals including mergers and acquisitions equitydebt offerings private equity venture financing and partnerships deals by year  jul   pages tso inc tos  medical equipment  deals and alliances profile us   deals database and primary and secondary research scope financial deals  analysis of the companys financial deals including mergers and acquisitions equitydebt offerings private equity venture financing and partnerships deals by year  jul   pages nymox pharmaceutical corp nymx  medical equipment  deals and alliances profile us   deals database and primary and secondary research scope financial deals  analysis of the companys financial deals including mergers and acquisitions equitydebt offerings private equity venture financing and partnerships deals by year  jul   pages safe orthopaedics sa safor  product pipeline analysis  update us   trial name trial objective sponsor trial design trial status and phase estimated start and end date reasons to buy develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape design and develop your product development  jun   pages icad inc icad  product pipeline analysis  update us   trial name trial objective sponsor trial design trial status and phase estimated start and end date reasons to buy develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape design and develop your product development  jun   pages exini diagnostics ab  product pipeline analysis  update us   trial name trial objective sponsor trial design trial status and phase estimated start and end date reasons to buy develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape design and develop your product development  jun   pages brainlab ag  product pipeline analysis  update us   trial objective sponsor trial design trial status and phase estimated start and end date reasons to buy develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape design and develop your product development marketing  jun   pages anteo diagnostics ltd ado  product pipeline analysis  update us   trial name trial objective sponsor trial design trial status and phase estimated start and end date reasons to buy develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape design and develop your product development  jun   pages telephonics corporation  strategic swot analysis review us   business divisions corporate strategy – globaldata’s summarization of the company’s business strategy swot analysis – a detailed analysis of the company’s strengths weakness opportunities and threats company history – progression of key events associated with the company major products and services  jul   pages psa group ug  financial and strategic swot analysis review us   business strategy swot analysis – a detailed analysis of the company’s strengths weakness opportunities and threats company history – progression of key events associated with the company major products and services – a list of major products services and brands of the company key competitors  jul   pages       skip to top market reports all categories need help     uk     usa infomarketpublisherscom sales and support         infomarketpublisherscom   marketpublisherscom about us our clients our publishers customer faq market reports new publications reports by regions pressreleases terms  conditions privacy policy return policy affiliate program join as publisher follow us bing places for business bing places for business sign in using your microsoft account work account google account facebook account dont have an account create one healthcor management lp private fund manager profile  predictiveops healthcor management lp   follow has potential conflicts firm overview healthcor management lp is an sec registered investment adviser ria the firm is based in new york ny united states as of the firms last sec filing on april   the firm has  employees and has  billion in regulatory assets under management raum form adv summary as of april   address information main address  west th street rd floor new york ny  united states  view on map adviser information legal name healthcor management lp business name healthcor management lp jurisdictiontype de limited partnership websites httpwwwhealthcormanagementcom sec status registered  approved registration date  registration information sec number  crd number  public reporting company no cik number lei number legal structure and domicile legal structure limited partnership legal domicile country united states legal domicile stateprovince de key figures summary regulatory assets under management raum  number of employees  advisory  number of clients  to  number of accounts  services fees and clients services offered portfolio management  investment companiesbusiness development companies portfolio management  pooled investment vehicles portfolio management  business or institutional clients fee type charged percentage of aum performancebased fees client types registered investment companies pooled investment vehicles pension and profit sharing plans significant red flags disclosure reporting pages drps none potential conflicts transactions in recommended securities related persons have custody of client assets or accounts related persons have custody of client securities back to top funds healthcor offshore master fund lp hedge fund cayman islands gav   reported   beneficial owners  of clients invested directorsmanagers healthcor offshore gp llc general partner feeder fund name healthcor offshore ltd healthcor lp healthcor sanatate offshore master fund lp hedge fund cayman islands gav   reported   beneficial owners  of clients invested directorsmanagers healthcor offshore ii gp llc general partner feeder fund name healthcor sanatate offshore lp healthcor coinvest sanatate master fund lp hedge fund cayman islands gav   reported   beneficial owners  of clients invested directorsmanagers healthcor offshore iii gp llc general partner feeder fund name healthcor coinvest sanatate fund lp healthcor hybrid offshore master fund lp hedge fund cayman islands gav   reported   beneficial owners  of clients invested directorsmanagers healthcor hybrid offshore gp llc general partner feeder fund name healthcor hybrid offshore ltd other advisers healthcor partners management lp back to top books and records locations adp one penn plaza new york new york  united states phone  global relay  cambie st nd floor vancouver bc vb m canada phone  healthcor management uk lp phone  healthcor management lp  south main street  norwalk connecticut  united states phone  hedgeop compliance llc  park avenue th floor new york new york  united states phone  fax  mc corporate services po box gt ugland house south church street george town grand cayman cayman islands phone  morgan stanley fund services bermuda ltd and morgan stanley fund services ireland limited  sir john rogersons quay dublin  ireland phone  fax  morgan stanley fund services usa llc  westchester avenue purchase new york  united states phone  fax  sungard availability services data center  spring garden street philadelphia pennsylvania  united states phone  back to top service providers administrators morgan stanley fund services bermuda limited dublin  ireland auditors ernst  young new york new york united states custodians citibank new york new york united states fidelity capital markets boston massachusetts united states goldman sachs  co and affiliated qualified custodians new york new york united states jp morgan chase bank na newark delaware united states morgan stanley  co llc and affiliated qualified custodians new york new york united states marketers eaton partners llc rowayton new jersey united states prime brokers fidelity capital markets services boston massachusetts united states goldman sachs  co new york new york united states jpmorgan chase bank na newark delaware united states morgan stanley  co llc new york new york united states back to top control persons direct owners anabelle perez gray control person chief compliance officer and general counsel since  ownership percentage less than  arthur bruce cohen control person partner and coceo since  ownership percentage more than  but less than  avi daniel horev control person senior partner portfolio manager since  ownership percentage less than  christine clarke control person chief financial officer since  ownership percentage less than  healthcor associates llc control person general partner of healthcor management lp since  ownership percentage less than  joseph patrick healey control person partner and coceo since  ownership percentage more than  but less than  indirect owners arthur bruce cohen control person managing member since  owned through healthcor associates llc ownership percentage more than  but less than  joseph patrick healey control person managing member since  owned through healthcor associates llc ownership percentage more than  but less than  back to top other offices private residence phone   public office  south main street  norwalk connecticut  united states phone  back to top relying advisers healthcor capital lp healthcor group healthcor hybrid offshore gp llc healthcor management uk llp healthcor offshore gp llc healthcor offshore ii gp llc healthcor offshore iii gp llc healthcor partners ii lp healthcor partners management lp healthcor partners lp back to top view source data and changes healthcor management lp closes position in cnat  conatus pharmaceuticals inc  fintelio healthcor management lp closes position in cnat  conatus pharmaceuticals inc securitycnat  conatus pharmaceuticals inc institutionhealthcor management lp shares value   ownership  february    healthcor management lp has filed a sc ga form disclosing ownership of  shares of conatus pharmaceuticals inc nasdaqcnat corresponding to an  ownership percentage other investors with closed positions include credit suisse ag  springbok capital management llc and hall kathryn a conatus pharmaceuticals inc has declared a standard industrial code sic of  which is the pharmaceutical preparations industry healthcor management lp s top industries are agricultural services sic  engineering accounting research management and related services sic  and health services sic  healthcor managementmore info this page cnat  conatus pharmaceuticals incmore info healthcor management lp ownership holdings in conatus pharmaceuticals inc nasdaqcnat are shown in the following table dont miss an event create an alert dg filings this table shows a history of the dg filings made by the investor andor investor group note that the share values in this table are not directly comparable to any numbers shown in the f table if any filedateeffectivedateform prevshares reportedshares change in sharespercent ownershippercent change in ownershippercent   sc ga        sc ga        sc g   important note one of the primary uses of the dg filings is to evaluate the ability of a firm to control a company ie the beneficial ownership to that end firms are required to report not just direct holdings in companies but indirect holdings that they control for investment firms these indirect holdings can include shares in funds they manage advisory accounts and in the case of activist campaigns pledged votes therefore share counts listed in dg filings can differ significantly than share counts listed in f filings f filings the security class and cusip columns in the table below are shown exactly as filed by the investor we do our best to track continuity of investments through acquisitions and this will be reflected in the table as changes in names and cusips in addition to descriptive data performance of the investment is shown over time to calculate quarterly performance we first calculate cost basis of the shares purchased during the quarter then use that to calculate gross profit quarterly return is gross profit  starting portfolio value note that cost basis is calculated and stored in thousands so small quarterly changes in shares frequently result in a cost basis of zero effectivedateform security class cusip shareprice shares change valuex change costx profitx return  fhr conatus pharmaceuticals com t      fhr conatus pharmaceuticals com t          fhr conatus pharmaceuticals com t          fhr conatus pharmaceuticals com t          fhr conatus pharmaceuticals com t          fhr conatus pharmaceuticals com t   fintel ir  find the right investors for your company instantly fintel ir combines the comprehensive fintel ownership database with machine learning to provide advanced tools to make investor outreach fast and easy learn more now cusip t iex realtime price become a power user join our private investing channel request membership healthcor management lp institutional portfolio  nasdaqcom hot topics etfs  smart portfolio  currencies  online broker center search home  quotes  ownership  insider trades  institutional portfolio healthcor management lp  west th street rd floor new york new york    report date  position statistics total positions  new positions  increased positions  decreased positions  positions with activity  sold out positions  total mkt value in  millions  institutional holdings information is filed by major institutions on form f with the securities and exchange commission sector weighting energy basic materials  industrials consumer cyclicals consumer noncyclicals financials healthcare  technology telecommunication services utilities total positions new increased decreased activity sold out  positions as of  company class value of shares s ▼ change in value s change  shares held bioverativ inc com   new  aetna inc new com     celgene corp com     laboratory corp amer hldgs com new     vertex pharmaceuticals inc com   new  edwards lifesciences corp com   new  intuitive surgical inc com new     alexion pharmaceuticals inc com     inc resh hldgs inc cl a     merck  co inc com     align technology inc com     haemonetics corp com     sarepta therapeutics inc com   new  qiagen nv shs new     neurocrine biosciences inc com     pacira pharmaceuticals inc com     zoetis inc cl a   new  baxter intl inc com     alere inc com   new  monsanto co new com      first previousnext last  latest news headlines sprint proposes merger with charter communications  wsj pm et   reuters union cheers as trucks kept out of us selfdriving legislation pm et   reuters rpthundreds of us counties at risk for no obamacare insurer in  pm et   reuters wells fargo faces angry questions after new sales abuses uncovered pm et   reuters us regulators weigh future of appeal in metlife case pm et   reuters view all latest headlines closex edit favorites enter up to  symbols separated by commas or spaces in the text box below these symbols will be available during your session for use on applicable pages update clear list closex customize your nasdaqcom experience background color selector select the background color of your choice  black  slate gray  light gray  gray blue quote search select a default target page for your quote search  realtime  after hours  premarket  news  flash quote  summary quote  interactive charts  default setting please note that once you make your selection it will apply to all future visits to nasdaqcom if at any time you are interested in reverting to our default settings please select default setting above if you have any questions or encounter any issues in changing your default settings please email isfeedbacknasdaqcom closex please confirm your selection you have selected to change your default setting for the quote search this will now be your default target page unless you change your configuration again or you delete your cookies are you sure you want to change your settings yes no closex please disable your ad blocker or update your settings to ensure that javascript and cookies are enabled so that we can continue to provide you with the firstrate market news and data youve come to expect from us closex